Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome

Christopher J. Logothetis; Andrew W. Hahn

doi:10.1016/j.eururo.2023.04.015

Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome

Christopher J. Logothetis, Andrew W. Hahn

Genitourinary Medical Oncology

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	3-7
Number of pages	5
Journal	European urology
Volume	85
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2023.04.015
State	Published - Jan 2024

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.eururo.2023.04.015

Cite this

@article{5be520aad5114f35a53a45062a5f52bf,

title = "Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome",

author = "Logothetis, {Christopher J.} and Hahn, {Andrew W.}",

note = "Funding Information: Acknowledgments : Andrew W. Hahn is supported by a Rob Heyvaert and Paul Heynen Prostate Cancer Foundation Young Investigator Award, an Early Investigator Research Award from the Department of Defense, a Conquer Cancer Foundation Young Investigator Award supported by AstraZeneca, and philanthropic donations from Michael and Patricia Berns. The authors would like to thank Sarah E. Townsend for editorial support, Ahmed O. Elmehrath and Omar Alhalabi for assistance in producing the SEER figure, and Rachel Davidowitz for assistance with the medical illustration in Figure 1 . ",

year = "2024",

month = jan,

doi = "10.1016/j.eururo.2023.04.015",

language = "English (US)",

volume = "85",

pages = "3--7",

journal = "European urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "1",

}

TY - JOUR

T1 - Challenging the Prevailing Therapeutic Dogma for Prostate Cancer

T2 - The Case for an Overlap Syndrome

AU - Logothetis, Christopher J.

AU - Hahn, Andrew W.

N1 - Funding Information: Acknowledgments : Andrew W. Hahn is supported by a Rob Heyvaert and Paul Heynen Prostate Cancer Foundation Young Investigator Award, an Early Investigator Research Award from the Department of Defense, a Conquer Cancer Foundation Young Investigator Award supported by AstraZeneca, and philanthropic donations from Michael and Patricia Berns. The authors would like to thank Sarah E. Townsend for editorial support, Ahmed O. Elmehrath and Omar Alhalabi for assistance in producing the SEER figure, and Rachel Davidowitz for assistance with the medical illustration in Figure 1 .

PY - 2024/1

Y1 - 2024/1

UR - http://www.scopus.com/inward/record.url?scp=85159885887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159885887&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2023.04.015

DO - 10.1016/j.eururo.2023.04.015

M3 - Editorial

C2 - 37210287

AN - SCOPUS:85159885887

SN - 0302-2838

VL - 85

SP - 3

EP - 7

JO - European urology

JF - European urology

IS - 1

ER -

Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this